3.2—Vitamin K2-Based Therapy for Mitochondrial Disease

Vitamin K2 to target and inhibit the progression of neurological and developmental deficiencies tied to mitochondrial DNA mutations.

Inventor: Ding Xue (CU Boulder Molecular, Cellular & Developmental Biology)

Potential Applications: Health and Wellness, Therapeutics